Far Infrared Treatment for Alzheimer's Disease

Phase 1

• Conditions: Alzheimer Disease
• Interventions: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)

• Registration Number: NCT00599469
• Lead Sponsor: GAAD Medical Research Institute Inc.

Brief Summary

Alzheimer's disease is a progressive and fatal brain disease. This study will investigate the use of far infrared radiation treatment for the disease.

Detailed Description

Alzheimer's destroys brain cells, causing problems with memory, thinking and behaviour severe enough to affect work, lifelong hobbies or social life. Alzheimer's gets worse over time and it is fatal.

Alzheimer's, which has no current cure, is the most common form of dementia. It is hereby postulated that far infrared radiation of the central nervous and endocrine systems will help with the management of the disease and possibly cure the disease.

Study Timeline

• Study First Submitted: 2008-01-11
• Study First Submitted QC: 2008-01-11
• Study First Posted: 2008-01-23
• Study Start: 2008-02
• Primary Completion: 2009-03
• Study Completion: 2009-04
• Status Verified: 2009-08
• Last Update Submitted: 2009-08-14
• Last Update Posted: 2009-08-17

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 4

Inclusion Criteria

• People with Alzheimer's disease

Exclusion Criteria

• None

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1	Far Infrared Radiation (5μm to 20μm wavelength)	Far Infrared Radiation

Primary Outcome Measures

Name	Time	Method
Management and Cure of Alzheimer's Disease	1 year

Secondary Outcome Measures

Name	Time	Method
Management and Cure of Dementia	1 year

Trial Locations

Locations (1)

The Centre for Incurable Diseases; 🇨🇦 Toronto, Ontario, Canada